| 2020 | | Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea | 박광주, 박범희, 박재범, 박주헌, 박지은, 박해심, 신승수, 황성철 |
| 2010 | | Emphysema as a risk factor for the outcome of surgical resection of lung cancer. | 박경주, 박광주, 박주헌, 선주성, 신승수, 이규성, 이성수, 정우영, 최호, 황성철 |
| 2005 | | Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. | 박광주, 신승수, 오윤정, 이기범, 한재호, 황성철 |
| 2006 | | Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. | 박광주, 박래웅, 박주헌, 신승수, 오윤정, 이규성, 최영화, 황성철 |
| 2007 | | Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer. | 신승수, 안영실, 오윤정, 윤준기, 황성철 |
| 2018 | | Redox- and pH-Responsive Nanoparticles Release Piperlongumine in a Stimuli-Sensitive Manner to Inhibit Pulmonary Metastasis of Colorectal Carcinoma Cells | 황성철 |
| 2007 | | Serum angiopoietin-2 as a clinical marker for lung cancer. | 박광주, 박주헌, 신승수, 오윤정, 이규성, 황성철 |
| 2006 | | The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis. | 강승희, 김효철, 박광주, 박준성, 신승수, 오영택, 오윤정, 이현우, 전미선, 최진혁, 황성철 |
| 1999 | | The clinical usefulness of F-18 FDG coincidence PET without attenuation correction and without whole-body scanning mode in pulmonary lesions comparison with CT, MRI, and clinical findings. | 박찬희, 이철주, 한명호, 황성철 |
| 2001 | | Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts. | 강승희, 김현수, 김효철, 남동기, 박광주, 오영택, 이이형, 임호영, 전미선, 최진혁, 황성철 |
